Diabetes News and Research

Latest Diabetes News and Research

Soda consumers may get much higher dose of harmful sugar fructose than labels show

Soda consumers may be getting a much higher dose of the harmful sugar fructose than they have been led to believe, according to a new study by the Childhood Obesity Research Center (CORC) at the Keck School of Medicine of the University of Southern California (USC), part of Keck Medicine of USC.

5 Jun 2014

PointRight releases PointRight Pro 30 to track and reduce rehospitalization rates

PointRight Inc., providing industry-standard analytics for healthcare providers and payers, announces the release of PointRight® Pro 30™, an upgraded version of its popular tools leveraging big data to track and reduce rehospitalization rates in long-term care (LTC) facilities.

5 Jun 2014

NantHealth to unveil open Clinical Operating System at NHS Confederation Annual Conference and Exhibition

NantHealth, a transformational healthcare company converging science and technology through a single integrated clinical platform, will unveil the industry's first, open Clinical Operating System (cOS) for value-based, coordinated care at this year's NHS Confederation Annual Conference and Exhibition.

4 Jun 2014

SYNERA can help prevent needle stick pain associated with superficial IVs

Galen US Incorporated today announced that the U.S. Food and Drug Administration (FDA) recently approved a labeling change that allows SYNERA® (lidocaine and tetracaine) topical patch to be used at home.

4 Jun 2014

New app for smartphones automatically calculates carbohydrate content of meal

An app for smartphones automatically calculates the carbohydrate content of a meal. The programme called "GoCARB" enables diabetics to better plan their meals and to control their blood glucose easier.

4 Jun 2014

New therapies for kidney disease can be developed by revising definition of kidney disease

A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health suggests that new therapies for kidney disease could be developed more quickly by revising the definition of kidney disease progression used during clinical trials.

4 Jun 2014

First Edition: June 4, 2014

Today's headlines include a story about the costs some states will face in attempting to fix their online insurance marketplace.

4 Jun 2014

Researchers emphasize critical need to utilize multi-pronged approach to treat diabetes mellitus

Charles H. Hennekens, M.D., Dr.P.H., the first Sir Richard Doll professor and senior academic advisor to the dean in the Charles E. Schmidt College of Medicine at Florida Atlantic University; Marc A. Pfeffer, M.D., Dzau professor of medicine at Harvard Medical School; John W. Newcomer, M.D., executive vice dean of FAU's College of Medicine and interim vice president for research at FAU; Paul S. Jellinger, M.D., affiliate professor at the University of Miami Miller School of Medicine; and Alan Garber, M.D., Ph.D., professor of medicine at Baylor, have published a commentary in the American Journal of Managed Care titled "Treatment of Diabetes Mellitus: The Urgent Need for Multifactorial Interventions."

4 Jun 2014

Georgia State University establishes new research center to help fight obesity epidemic

The Center for Obesity Reversal, a new top-level research center at Georgia State University, has been established to foster research projects that will help fight the nation's obesity epidemic.

4 Jun 2014

KineMed renews non-exclusive research collaboration with Pfizer

KineMed Inc. today announced the renewal of a non-exclusive research collaboration with Pfizer Inc. for the advancement of novel approaches in metabolic disease, in particular Type II diabetes.

4 Jun 2014

Researchers find way to prevent nonalcoholic fatty liver disease

Studying mice, researchers have found a way to prevent nonalcoholic fatty liver disease, the most common cause of chronic liver disease worldwide.

4 Jun 2014

AFFiRiS releases positive study results of AD04 therapeutic drug in Alzheimer patients

AFFiRiS announced today the results of a phase II study in Alzheimer patients. AFFiRiS' proprietary compound AD04 is the first drug ever to demonstrate clinical and biomarker effects consistent with disease modification in Alzheimer patients.

4 Jun 2014

New vaccine effective at preventing lung cancer in mice

Tweaking a protein expressed by most liver cancer cells has enabled scientists to make a vaccine that is exceedingly effective at preventing the disease in mice.

4 Jun 2014

NeuroVive extends collaboration with Hospices Civils de Lyon

NeuroVive is extending its collaboration with Hospices Civils de Lyon (HCL) and Professor Ovize, which broadens the scope of NeuroVive's cardiovascular business area and creates the right conditions for the company to retain its leading position in mitochondrial medicine.

4 Jun 2014

Brown University researchers develop new biochip sensor to measure glucose levels in saliva

Researchers from Brown University have developed a new biochip sensor that can selectively measure concentrations of glucose in a complex solution similar to human saliva. The advance is an important step toward a device that would enable people with diabetes to test their glucose levels without drawing blood.

4 Jun 2014

Study results suggest growing support for patient-centered care management

Primary care doctors practicing in a model of coordinated, team-based care that leverages health information technology are more likely to give patients recommended preventive screening and appropriate tests than physicians working in other settings, according to research published today in the Annals of Internal Medicine.

4 Jun 2014

Salk Institute receives $25 million for cutting-edge biological research

The Salk Institute for Biological Studies has received a $25 million gift from San Diego philanthropist and former Salk trustee Conrad T. Prebys to support cutting-edge biological research on a wide range of diseases.

3 Jun 2014

Resveratrol supplements during pregnancy linked to developmental abnormalities in fetal pancreas

New research in The FASEB Journal suggests that although resveratrol improved blood flow through the placenta of macaque monkeys and protected against harmful aspects of obesity, resveratrol injured the fetal pancreas.

3 Jun 2014

Older, obese women with diabetes and on dialysis at risk for calciphylaxis

Obese, Caucasian females over age 50 with diabetes and on dialysis because their kidneys have failed are among those at highest risk for the rare and deadly condition calciphylaxis, according to an analysis of the United States Renal Data System.

3 Jun 2014

Study warns against use of resveratrol supplements by pregnant women

A widely available dietary supplement that had been considered safe - and that some claim provides anti-aging and other health benefits - caused significant developmental abnormalities in the pancreas of offspring of pregnant monkeys who were given the supplement, according to a study published today in the FASEB Journal, from the Federation of American Societies of Experimental Biology.

3 Jun 2014

Diabetes News and Research

Latest Diabetes News and Research

Soda consumers may get much higher dose of harmful sugar fructose than labels show

PointRight releases PointRight Pro 30 to track and reduce rehospitalization rates

NantHealth to unveil open Clinical Operating System at NHS Confederation Annual Conference and Exhibition

SYNERA can help prevent needle stick pain associated with superficial IVs

New app for smartphones automatically calculates carbohydrate content of meal

New therapies for kidney disease can be developed by revising definition of kidney disease

First Edition: June 4, 2014

Researchers emphasize critical need to utilize multi-pronged approach to treat diabetes mellitus

Georgia State University establishes new research center to help fight obesity epidemic

KineMed renews non-exclusive research collaboration with Pfizer

Researchers find way to prevent nonalcoholic fatty liver disease

AFFiRiS releases positive study results of AD04 therapeutic drug in Alzheimer patients

New vaccine effective at preventing lung cancer in mice

NeuroVive extends collaboration with Hospices Civils de Lyon

Brown University researchers develop new biochip sensor to measure glucose levels in saliva

Study results suggest growing support for patient-centered care management

Salk Institute receives $25 million for cutting-edge biological research

Resveratrol supplements during pregnancy linked to developmental abnormalities in fetal pancreas

Older, obese women with diabetes and on dialysis at risk for calciphylaxis

Study warns against use of resveratrol supplements by pregnant women

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Diabetes News and Research

Latest Diabetes News and Research

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in